- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.12.25 | EirGenix Licenses Transcenta's HiCB Platform to Improve Process Efficiency | ||
| 29.12.25 | Senhwa Aims to Enter Global ADC Market with Combination Cancer Therapy | ||
| 29.12.25 | Novo Nordisk's Wegovy Pill Wins U.S. Approval | ||
| 29.12.25 | BioMarin to Acquire Amicus Therapeutics for $4.8B | ||
| 23.12.25 | Samsung Bioepis' Stelara Biosimilar Approved in Japan | ||
| 22.12.25 | 9 Pharmaceutical Companies Enter Agreement with Trump to Lower Medicine Costs | ||
| 22.12.25 | Symbiosis Begins Commercial Manufacturing at Stirling, UK Facility | ||
| 22.12.25 | Rectify Pharmaceuticals, Boehringer Ingelheim Partner to Accelerate Treatments for CKD | ||
| 18.12.25 | Chitose, Fujifilm Biosciences Partner to Advance Biopharmaceutical Manufacturing | ||
| 18.12.25 | Gilead Sciences Appoints Keeley Wettan as EVP, General Counsel, Legal & Compliance | ||
| 17.12.25 | Galux, Boehringer Ingelheim to Jointly Explore AI in Precision Protein Design | ||
| 17.12.25 | Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies | ||
| 17.12.25 | FDA Approves Exdensur for Severe Asthma | ||
| 17.12.25 | MEDI&GENE Enters Catalyze Agreement with Lilly to Advance Obesity Therapeutic | ||
| 16.12.25 | Takeda Joins BaseLaunch Biotech Venture Incubator | ||
| 16.12.25 | TreeFrog Therapeutics Names Mark Rothera as CEO | ||
| 16.12.25 | ADEL Enters Global License Agreement with Sanofi for ADEL-Y01 | ||
| 16.12.25 | Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials | ||
| 16.12.25 | Leadership Changes at NorthStar Medical Radioisotopes | ||
| 16.12.25 | EMA Approves Grifols Egypt's Full Plasma Value Chain | ||
| 15.12.25 | Thermo Fisher Expands Gibco Bacto CD Portfolio with New E. coli Media | ||
| 15.12.25 | Dren Bio Expands Strategic Collaboration with Sanofi | ||
| 15.12.25 | Gaelic Laboratories Acquires Athlone Laboratories | ||
| 15.12.25 | SOBI Agrees to Acquire Arthrosi Therapeutics | ||
| 12.12.25 | Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.